LGND
Price
$101.31
Change
-$1.14 (-1.11%)
Updated
May 22, 04:59 PM (EDT)
Capitalization
2.02B
81 days until earnings call
LOGC
Price
$7.73
Change
-$0.32 (-3.98%)
Updated
May 22, 04:59 PM (EDT)
Capitalization
205.71M
Interact to see
Advertisement

LGND vs LOGC

Header iconLGND vs LOGC Comparison
Open Charts LGND vs LOGCBanner chart's image
Ligand Pharmaceuticals
Price$101.31
Change-$1.14 (-1.11%)
Volume$300
Capitalization2.02B
ContextLogic
Price$7.73
Change-$0.32 (-3.98%)
Volume$17.13K
Capitalization205.71M
LGND vs LOGC Comparison Chart
Loading...
LGND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LOGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LGND vs. LOGC commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LGND is a Hold and LOGC is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
May 23, 2025
Stock price -- (LGND: $102.45 vs. LOGC: $8.05)
Brand notoriety: LGND and LOGC are both not notable
LGND represents the Biotechnology, while LOGC is part of the Internet Retail industry
Current volume relative to the 65-day Moving Average: LGND: 71% vs. LOGC: 76%
Market capitalization -- LGND: $2.02B vs. LOGC: $205.71M
LGND [@Biotechnology] is valued at $2.02B. LOGC’s [@Internet Retail] market capitalization is $205.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $305.18B to $0. The market cap for tickers in the [@Internet Retail] industry ranges from $2.16T to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B. The average market capitalization across the [@Internet Retail] industry is $42.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LGND’s FA Score shows that 0 FA rating(s) are green whileLOGC’s FA Score has 0 green FA rating(s).

  • LGND’s FA Score: 0 green, 5 red.
  • LOGC’s FA Score: 0 green, 5 red.
According to our system of comparison, LOGC is a better buy in the long-term than LGND.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LGND’s TA Score shows that 3 TA indicator(s) are bullish while LOGC’s TA Score has 6 bullish TA indicator(s).

  • LGND’s TA Score: 3 bullish, 7 bearish.
  • LOGC’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, LOGC is a better buy in the short-term than LGND.

Price Growth

LGND (@Biotechnology) experienced а -2.51% price change this week, while LOGC (@Internet Retail) price change was +9.23% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.82%. For the same industry, the average monthly price growth was +7.45%, and the average quarterly price growth was -1.67%.

The average weekly price growth across all stocks in the @Internet Retail industry was +2.75%. For the same industry, the average monthly price growth was +10.35%, and the average quarterly price growth was +38.74%.

Reported Earning Dates

LGND is expected to report earnings on Aug 11, 2025.

LOGC is expected to report earnings on May 09, 2025.

Industries' Descriptions

@Biotechnology (+4.82% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Internet Retail (+2.75% weekly)

The internet retail industry includes companies that sell products and services through the Internet. With more and more consumers using online retailers, the companies have seen a big increase in the use of their services. Some of the companies in the group are focused on selling business-to-business products and services. Others sell business-to-consumer products and services. Internet retailers offer a wide variety of products like books, apparel, and electronics. Some companies even specialize in only one or two categories. One potentially critical factor for players to thrive in this space is the quality and speed of product delivery. This requires an investment in efficient distribution networks. Things like logistics are important factors in the success in the extremely competitive industry. For a company to stay relevant in the industry it must have effective pricing strategies and upgraded websites. The websites must be easy to navigate and engaging for customers. In addition to the revenues generated from straight sales, internet retailers can generate revenue from subscription fees and advertising. Amazon.com, Inc., Alibaba Group, and JD.com are some of the global leaders.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LGND($2.02B) has a higher market cap than LOGC($206M). LOGC YTD gains are higher at: 14.509 vs. LGND (-4.386). LOGC has higher annual earnings (EBITDA): -78M vs. LGND (-122.1M). LGND has more cash in the bank: 209M vs. LOGC (149M). LOGC has less debt than LGND: LOGC (0) vs LGND (4.45M). LGND has higher revenues than LOGC: LGND (181M) vs LOGC (43M).
LGNDLOGCLGND / LOGC
Capitalization2.02B206M983%
EBITDA-122.1M-78M157%
Gain YTD-4.38614.509-30%
P/E Ratio46.19N/A-
Revenue181M43M421%
Total Cash209M149M140%
Total Debt4.45M0-
FUNDAMENTALS RATINGS
LGND vs LOGC: Fundamental Ratings
LGND
LOGC
OUTLOOK RATING
1..100
6527
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
54
Fair valued
PROFIT vs RISK RATING
1..100
6299
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
5941
P/E GROWTH RATING
1..100
90100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LOGC's Valuation (54) in the Pharmaceuticals Major industry is in the same range as LGND (76) in the Biotechnology industry. This means that LOGC’s stock grew similarly to LGND’s over the last 12 months.

LGND's Profit vs Risk Rating (62) in the Biotechnology industry is somewhat better than the same rating for LOGC (99) in the Pharmaceuticals Major industry. This means that LGND’s stock grew somewhat faster than LOGC’s over the last 12 months.

LGND's SMR Rating (100) in the Biotechnology industry is in the same range as LOGC (100) in the Pharmaceuticals Major industry. This means that LGND’s stock grew similarly to LOGC’s over the last 12 months.

LOGC's Price Growth Rating (41) in the Pharmaceuticals Major industry is in the same range as LGND (59) in the Biotechnology industry. This means that LOGC’s stock grew similarly to LGND’s over the last 12 months.

LGND's P/E Growth Rating (90) in the Biotechnology industry is in the same range as LOGC (100) in the Pharmaceuticals Major industry. This means that LGND’s stock grew similarly to LOGC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LGNDLOGC
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 7 days ago
75%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
71%
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 18 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
LGND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LOGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GGEYX27.23N/A
N/A
GuideStone Funds Growth Equity Instl
RIVSX17.05N/A
N/A
River Oak Discovery
TBCUX16.40N/A
N/A
Tweedy, Browne Intl Val II - Ccy UnH
GQJIX11.24N/A
N/A
GQG Partners Intl Qual Val Fd Ins
JHUJX32.27-0.16
-0.49%
JPMorgan Emerging Markets Equity R2

LGND and

Correlation & Price change

A.I.dvisor indicates that over the last year, LGND has been loosely correlated with ACLX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if LGND jumps, then ACLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LGND
1D Price
Change %
LGND100%
-2.35%
ACLX - LGND
51%
Loosely correlated
+8.26%
ROIV - LGND
49%
Loosely correlated
-1.18%
AXON - LGND
49%
Loosely correlated
-0.99%
SYRE - LGND
47%
Loosely correlated
-4.03%
CRSP - LGND
46%
Loosely correlated
-5.76%
More